These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6212595)

  • 1. Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazone.
    Thornsberry C; Barry AL; Jones RN; Baker CN; Badal RE
    J Clin Microbiol; 1982 May; 15(5):769-76. PubMed ID: 6212595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.
    Jones RN; Gavan TL; Barry AL; Thornsberry C; Gibbs DL
    J Clin Microbiol; 1982 May; 15(5):777-86. PubMed ID: 6212596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented media.
    Jones RN; Barry AL; Thornsberry C
    Diagn Microbiol Infect Dis; 1986 Apr; 4(4):345-9. PubMed ID: 3698547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests.
    Jones RN; Barry AL; Thornsberry C; Wilson HW
    Am J Clin Pathol; 1985 Oct; 84(4):496-504. PubMed ID: 2994461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.
    Ayers LW; Jones RN; Barry AL; Thornsberry C; Fuchs PC; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1982 Nov; 22(5):859-77. PubMed ID: 6983862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefoperazone: spectrum of antibacterial activity and disc diffusion testing.
    Thornsberry C; Jones RN
    Drugs; 1981; 22 Suppl 1():3-12. PubMed ID: 6456889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility test.
    Barry AL; Jones RN; Thornsberry C
    Antimicrob Agents Chemother; 1981 Oct; 20(4):525-9. PubMed ID: 6211134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility tests with cefotaxime and correlation with clinical bacteriologic response.
    Thornsberry C; Jones RN; Barry AL; Fuchs PC
    Rev Infect Dis; 1982; 4 Suppl():S316-24. PubMed ID: 6294780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT; Prignano G; Iegri F; Lorenzi A
    Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
    Jones RN; Barry AL; Thornsberry C
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):295-311. PubMed ID: 6321093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disk agar diffusion susceptibility testing with 30-micrograms ceftazidime disks: confirmation of interpretive breakpoints and quality control guidelines.
    Jones RN; Barry AL; Thornsberry C
    J Clin Microbiol; 1983 Jul; 18(1):211-4. PubMed ID: 6350348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of Ro 19-5247 (T-2525) and interpretive criteria for disk diffusion susceptibility testing.
    Beskid G; Fallat V; Siebelist J; Durkin JW; Lipschitz ER; McGarry DH
    J Clin Microbiol; 1987 Jul; 25(7):1186-90. PubMed ID: 3112176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of LY164846, a new oral cephalosporin, and recommendations for disk diffusion tests.
    Sassine-Nawas G; Baker CN; Thornsberry C
    Diagn Microbiol Infect Dis; 1987 Jan; 6(1):41-8. PubMed ID: 3100126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Error rates in cefoperazone and cefoperazone-sulbactam disk tests with Enterobacteriaceae and Pseudomonas aeruginosa.
    Hardy DJ; Barry AL; Fuchs PC; Gerlach EH; McLaughlin JC; Pfaller MA
    Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):926-30. PubMed ID: 1486889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefoperazone: regression analysis, disk content, and disk susceptibility testing considerations.
    Wright DN; Welch DF; Saxon BA; Clark SJ; Matsen JM
    Antimicrob Agents Chemother; 1982 Sep; 22(3):493-8. PubMed ID: 6215895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-strain regression analysis for determination of interpretive breakpoints for cefoperazone disk diffusion susceptibility testing.
    Kronvall G
    J Clin Microbiol; 1983 Jun; 17(6):975-80. PubMed ID: 6223938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of antibacterial activities of cephalosporins].
    Kayser FH; Kohler ML
    Schweiz Med Wochenschr; 1984 Feb; 114(5):156-61. PubMed ID: 6701496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories.
    Jones RN; Thornsberry C; Barry AL; Ayers L; Brown S; Daniel J; Fuchs PC; Gavan TL; Gerlach EH; Matsen JM
    J Clin Microbiol; 1984 Sep; 20(3):409-12. PubMed ID: 6490826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.
    Fuchs PC; Barry AL; Thornsberry C; Jones RN; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1980 Jul; 18(1):88-93. PubMed ID: 6251750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.